Relation between cardiovascular disease risk factors and epicardial adipose tissue density on cardiac computed tomography in patients at high risk of cardiovascular events

Abstract

Background

The radiodensity of epicardial adipose tissue may provide information on cardiovascular risk in addition to epicardial adipose tissue volume. The aim of this study was to quantify the relation between cardiovascular risk factors and the radiodensity of epicardial adipose tissue in patients at high risk of cardiovascular disease.

Design

This was a cross-sectional study in 140 patients at high risk of cardiovascular disease.

Methods

Patients from the Secondary Manifestations of ARTerial disease (SMART) cohort study were invited to undergo cardiac computed tomography angiography. The radiodensity (in Hounsfield units; HU) and volume (in cm³) of epicardial adipose tissue were quantified semi-automatically. Multivariable linear regression was used to quantify the relation between cardiovascular risk factors and the radiodensity of epicardial adipose tissue.

Results

The cardiovascular risk factors most strongly associated with epicardial adipose tissue density were sex, body mass index and visceral fat, with a lower adipose tissue attenuation of 3.5 HU (95% confidence interval (CI) 2.0–5.0 HU) for female sex, 1.6 HU (95%CI 0.2–2.9 HU) for body mass index >25 kg/m² and 1.3 HU (95% CI 0.6–2.0 HU) for a one standard deviation higher quantity of visceral fat, adjusted for age, sex, coronary artery bypass graft history and epicardial adipose tissue volume.

Conclusion

Low epicardial adipose tissue computed tomography attenuation is associated with an adverse cardiovascular risk factor profile in patients at high risk of cardiovascular disease, independent of the volume of epicardial adipose tissue and waist circumference. These findings support the potential role for epicardial adipose tissue radiodensity as a valid biomarker of cardiovascular risk. Adipose tissue radiodensity may be a more sensitive marker than epicardial adipose tissue volume with which to study the contribution of epicardial adipose tissue to the coronary atheromatous disease process.

Keywords

Epicardial adipose tissue computed tomography adipose tissue density adipose tissue attenuation coronary artery disease coronary atherosclerosis cardiovascular risk factors cardiovascular disease

Get full access to this article

View all access options for this article.

References

Dores

de Araujo Goncalves

Carvalho

. Body mass index as a predictor of the presence but not the severity of coronary artery disease evaluated by cardiac computed tomography. Eur J Prev Cardiol 2014; 21: 1387–1393.

Dudina

Cooney

Bacquer

. Relationships between body mass index, cardiovascular mortality, and risk factors: a report from the SCORE investigators. Eur J Cardiovasc Prev Rehabil 2011; 18: 731–742.

Hajer

van Haeften

Visseren

. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J 2008; 29: 2959–2971.

van Kruijsdijk

van der Wall

Visseren

. Obesity and cancer: the role of dysfunctional adipose tissue. Cancer Epidemiol Biomarkers Prev 2009; 18: 2569–2578.

Iacobellis

Bianco

. Epicardial adipose tissue: emerging physiological, pathophysiological and clinical features. Trends Endocrinol Metab 2011; 22: 450–457.

Alexopoulos

McLean

Janik

. Epicardial adipose tissue and coronary artery plaque characteristics. Atherosclerosis 2010; 210: 150–154.

Chung

Nayak

. Differential computed tomographic attenuation of metabolically active and inactive adipose tissues: preliminary findings. J Comput Assis Tomogr 2011; 35: 65–71.

Rosenquist

Massaro

Pedley

. Fat quality and incident cardiovascular disease, all-cause mortality, and cancer mortality. J Clin Endocrinol Metab 2015; 100: 227–234.

Murphy

Shively

. Adipose tissue density, a novel biomarker predicting mortality risk in older adults. J Gerontol Ser A Biol Sci Med Sci 2014; 69: 109–117.

10.

Ahmadi

Hajsadeghi

Conneely

. Accurate detection of metabolically active “brown” and “white” adipose tissues with computed tomography. Acad Radiol 2013; 20: 1443–1447.

11.

Baba

Jacene

Engles

. CT Hounsfield units of brown adipose tissue increase with activation: preclinical and clinical studies. J Nucl Med 2010; 51: 246–250.

12.

Ouellet

Labbe

Blondin

. Brown adipose tissue oxidative metabolism contributes to energy expenditure during acute cold exposure in humans. J Clin Invest 2012; 122: 545–552.

13.

Sacks

Fain

Bahouth

. Adult epicardial fat exhibits beige features. J Clin Endocrinol Metab 2013; 98: E1448–E1455.

14.

Lee JJ, Pedley A, Hoffmann U, et al. Cross-sectional associations of computed tomography (CT)-derived adipose tissue density and adipokines: the Framingham Heart Study. J Am Heart Assoc 2016; 5: e002545–e002545.

15.

Lee JJ, Britton KA, Pedley A, et al. Adipose tissue depots and their cross-sectional associations with circulating biomarkers of metabolic regulation. J Am Heart Assoc 2016; 5: 2047–9980.

16.

Simons

Algra

van de Laak

. Second manifestations of ARTerial disease (SMART) study: rationale and design. Eur J Epidemiol 1999; 15: 773–781.

17.

Stolk

Wink

Zelissen

. Validity and reproducibility of ultrasonography for the measurement of intra-abdominal adipose tissue. Int J Obes Relat Metab Disord 2001; 25: 1346–1351.

18.

Ainsworth

Haskell

Whitt

. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 2000; 32: S498–S504.

19.

Mihl

Loeffen

Versteylen

. Automated quantification of epicardial adipose tissue (EAT) in coronary CT angiography; comparison with manual assessment and correlation with coronary artery disease. J Cardiovasc Comput Tomogr 2014; 8: 215–221.

20.

Alvey NJ, Pedley A, Rosenquist KJ, et al. Association of fat density with subclinical atherosclerosis. J Am Heart Assoc 2014; 3.

21.

Rosenquist

Pedley

Massaro

. Visceral and subcutaneous fat quality and cardiometabolic risk. JACC Cardiovasc Imag 2013; 6: 762–771.

22.

Yeoh AJ, Pedley A, Rosenquist KJ, et al. The Association between Subcutaneous Fat Density and the Propensity to Store Fat Viscerally. J Clin Endocrinol Metab 2015: jc20144032.

23.

Pracon

Kruk

Kepka

. Epicardial adipose tissue radiodensity is independently related to coronary atherosclerosis. A multidetector computed tomography study. Circulation J 2011; 75: 391–397.

24.

Hirata

Tabata

Kurobe

. Coronary atherosclerosis is associated with macrophage polarization in epicardial adipose tissue. J Am Coll Cardiol 2011; 58: 248–255.

25.

Gaborit

Venteclef

Ancel

. Human epicardial adipose tissue has a specific transcriptomic signature depending on its anatomical peri-atrial, peri-ventricular, or peri-coronary location. Cardiovasc Res 2015; 108: 62–73.

26.

Weyer

Foley

Bogardus

. Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance. Diabetologia 2000; 43: 1498–1506.

27.

El Khoudary SR, Shields KJ, Janssen I, et al. Cardiovascular fat, menopause and sex hormones in women: the SWAN cardiovascular fat ancillary study. J Clin Endocrinol Metab 2015: JC20152110.

28.

Alexopoulos

Melek

Arepalli

. Effect of intensive versus moderate lipid-lowering therapy on epicardial adipose tissue in hyperlipidemic post-menopausal women: a substudy of the BELLES trial (Beyond Endorsed Lipid Lowering with EBT Scanning). J Am Coll Cardiol 2013; 61: 1956–1961.

29.

Psychari

Rekleiti

Papaioannou

. Epicardial fat in nonalcoholic fatty liver disease: properties and relationships with metabolic factors, cardiac structure, and cardiac function. Angiology 2016; 67: 41–48.

30.

Tanami

Jinzaki

Kishi

. Lack of association between epicardial fat volume and extent of coronary artery calcification, severity of coronary artery disease, or presence of myocardial perfusion abnormalities in a diverse, symptomatic patient population: results from the CORE320 multicenter study. Circ Cardiovasc Imag 2015; 8: e002676–e002676.

31.

Park

Ghemigian

. Epicardial and paracardial adipose tissue volume and attenuation – association with high-risk coronary plaque on computed tomographic angiography in the ROMICAT II trial. Atherosclerosis 2016; 251: 47–54.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.28 MB